arrow
G

Guilherme Fleury Perini

universidad autonoma de sinaloa
H指数:20
被引数:2,115

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping the capacity for geriatric blood Cancer Care in Latin America: A cross-sectional survey of current status and future priorities

绘制拉丁美洲老年血液癌症护理能力地图:一项关于当前状况和未来优先事项的横断面调查

2026-07-010
PRE
Peripheral blood or bone marrow grafts for mismatched unrelated donors with posttransplant cyclophosphamide-based graft-versus-host disease prophylaxis

供者外周血或骨髓移植,用于HLA不合的无关供者,并采用移植后环磷酰胺为基础的移植物抗宿主病预防方案。

2025-10-120
PRE
Real-world data on the clinical features, therapy patterns, and outcomes of older adults with diffuse large B-cell lymphoma in Latin America: A study from the Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL)
2025-01-010
PRE
Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

使用限制性立方样条分析炎症生物标志物与总生存期的剂量-反应关系:拉丁美洲淋巴增殖性疾病研究组(GELL)在一项弥漫大B细胞淋巴瘤队列中的经验

BLOOD
IF23.1
2024-11-050
PRE
Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

淋巴瘤预后生物标志物截断点选择:拉丁美洲淋巴增殖性疾病研究组(GELL)在弥漫大B细胞淋巴瘤患者队列中的经验,使用限制性立方样条法

BLOOD
IF23.1
2024-11-050
PRE
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
2022-06-30101
OA
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
2022-01-1913
OAAI
Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)
2020-09-010
OAAI
Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients-An analysis from the Brazilian Hodgkin Lymphoma Registry
2017-10-2617
OAAI
Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry

霍奇金淋巴瘤的治疗结果: 来自巴西前瞻性登记处的首份报告

2017-06-2311
PREAI